Daniel Nowak

14PUBLICATIONS

117CO-AUTHORS

Molecular targetsGene expression (incl. microarray and other genome-wide approaches)Medical infection agents (incl. prions)Haematological tumoursEpigenetics (incl. genome methylation and epigenomics)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (14)

Sort by Publication Date:

|Jun 18, 2026

Comprehensive molecular characterization of treatment-free remission and molecular relapse in chronic myeloid leukemia patients: the EURO-SKI Biomarker Study.

|Jan 29, 2026

Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences the risk of acute myeloid leukemia.

Diyanath Ranasinghe, Wei-Yu Lin, Sarah E Fordham

|Aug 21, 2025

The bispecific innate cell engager AFM28 eliminates CD123<sup>+</sup> leukemic stem and progenitor cells in AML and MDS.

Nanni Schmitt, Jana-Julia Siegler, Alexandra Beck

|Dec 09, 2024

Efficacy and safety of venetoclax plus azacitidine for patients with treatment-naive high-risk myelodysplastic syndromes.

Jacqueline S Garcia, Uwe Platzbecker, Olatoyosi Odenike

|May 28, 2024

Cell-type-specific consequences of mosaic structural variants in hematopoietic stem and progenitor cells.

Karen Grimes, Hyobin Jeong, Amanda Amoah

|Oct 06, 2023

Distinct and targetable role of calcium-sensing receptor in leukaemia.

Raquel S Pereira, Rahul Kumar, Alessia Cais

Pageof 3

Frequent Collaborators

4 joint publications

Johann-Christoph Jann

Wei-Yu Lin

Jude Fitzgibbon

Theresa Hahn

Claire Elstob

Richard A Larson

David J Allsup

Matthew Collin

Christian Gieger

Nanni Schmitt

Frequent Collaborators

4 joint publications

Johann-Christoph Jann

3 joint publications

Wei-Yu Lin

3 joint publications

Jude Fitzgibbon

3 joint publications

Theresa Hahn